Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the optimal timing of first-line antiretroviral therapy
- Summarize the data supporting the preferred and alternative antiretroviral regimens in the current European guidelines
- Describe the role of novel agents in first-line antiretroviral therapy
Topics covered include:
-
The optimal time to start antiretroviral therapy according to the most recent European guidelines
-
Similarities and differences between preferred first-line regimens in European guidelines and other consensus guidelines
-
How emerging data may impact future European guidelines
Abstract